Skip to content
Search

Latest Stories

GPhC appoints Rose Marie Parr, two others as new Council members

The General Pharmaceutical Council (GPhC) has appointed three new members, including the outgoing Chief Pharmaceutical Officer for Scotland Rose Marie Parr, to its governing body.

The terms of new joiners Parr, Selina Ullah and Yousaf Ahmad will begin on April 1, 2020.


They are replacing Alan Kershaw, Digby Emson OBE and Evelyn McPhail, who are standing down after serving two terms on the Council.

In a statement issued today, Nigel Clarke, Chair of the GPhC, said: “I am delighted to announce the appointments of Rose Marie, Selina and Yousaf. Each of them brings a wealth of high-level experience and expertise – they will be valuable assets to the Council.”

The GPhC began its recruitment campaign in July last year, seeking three Council members, including two registered pharmacy professionals and one non-health professional members.

While Parr and Ahmad have pharmacy background, Ullah is joining the Council as a ‘lay’ member.

Parr, who has been the Chief Pharmaceutical Officer for Scotland since 2015, is retiring from the role in July 2020. She was previously the chair of Scottish Pharmacy Board of the Royal Pharmaceutical Society and also served as the chair of GPhC’s Board of Assessors, which oversees the registration assessment.

Selina Ullah is the deputy chair and senior independent director of Bradford Teaching Hospitals NHS Foundation Trust, board member of Locala Community Partnerships CIC, non-executive director of Accent Group and chair of various charities. She has over 25 years of non-executive board experience.

Ahmad, who was part of the UKCPA and RPS bodies, is currently the Chief Pharmacist of Care UK Healthcare group that covers primary, secondary, health in justice and residential care.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less